Patent Grant
11974846
The present disclosure relates generally to devices, assemblies, and systems adapted for use with vascular access devices. More particularly, the present disclosure relates to devices, assemblies, and systems adapted for collecting biological samples for use in point-of-care testing.
Blood sampling is a common health care procedure involving the withdrawal of at least a drop of blood from a patient. Blood samples are commonly taken from hospitalized, homecare, and emergency room patients either by finger stick, heel stick, or venipuncture. Blood samples may also be taken from patients by venous or arterial lines. Once collected, blood samples may be analyzed to obtain medically useful information including chemical composition, hematology, or coagulation, for example.
Blood tests determine the physiological and biochemical states of the patient, such as disease, mineral content, drug effectiveness, and organ function. Blood tests may be performed in a clinical laboratory or at the point-of-care near the patient. One example of point-of-care blood testing is the routine testing of a patient's blood glucose levels which involves the extraction of blood via a finger stick and the mechanical collection of blood into a diagnostic cartridge. Thereafter, the diagnostic cartridge analyzes the blood sample and provides the clinician a reading of the patient's blood glucose level. Other devices are available which analyze blood gas electrolyte levels, lithium levels, and ionized calcium levels. Some other point-of-care devices identify markers for acute coronary syndrome (ACS) and deep vein thrombosis/pulmonary embolism (DVT/PE).
Despite the rapid advancement in point-of-care testing and diagnostics, blood sampling techniques have remained relatively unchanged. Blood samples are frequently drawn using hypodermic needles or vacuum tubes attached to a proximal end of a needle or a catheter assembly. In some instances, clinicians collect blood from a catheter assembly using a needle and syringe that is inserted into the catheter to withdraw blood from a patient through the inserted catheter. These procedures utilize needles and vacuum tubes as intermediate devices from which the collected blood sample is typically withdrawn prior to testing. These processes are thus device intensive, utilizing multiple devices in the process of obtaining, preparing, and testing blood samples. Each additional device increases the time and cost of the testing process.
Point-of-care testing devices allow for a blood sample to be tested without needing to send the blood sample to a lab for analysis. Thus, it is desirable to create a device that provides an easy, safe, reproducible, and accurate process with a point-of-care testing system.
The present disclosure provides a biological fluid sampling transfer device, such as a blood sampling transfer device that is adapted to receive a blood sample having a cellular portion and a plasma portion. After collecting the blood sample, the blood sampling transfer device is able to separate the plasma portion from the cellular portion. After separation, the blood sampling transfer device is able to transfer the plasma portion of the blood sample to a point-of-care testing device. The blood sampling transfer device of the present disclosure also provides a closed sampling and transfer system that reduces the exposure of a blood sample and provides fast mixing of a blood sample with a sample stabilizer. The sample stabilizer can be an anticoagulant, or a substance designed to preserve a specific element within the blood such as, for example, RNA, protein analyte, or other element. The blood sampling transfer device is engageable with a blood testing device for closed transfer of a portion of the plasma portion from the blood sampling transfer device to the blood testing device. The blood testing device is adapted to receive the plasma portion to analyze the blood sample and obtain test results.
Some of the advantages of the blood sampling transfer device and the biological fluid separation and testing system of the present disclosure over prior systems are that it is a closed system which reduces blood sample exposure, it provides passive and fast mixing of the blood sample with a sample stabilizer, it facilitates separation of the blood sample without transferring the blood sample to a separate device, and it is capable of transferring pure plasma to a point-of-care testing device. The blood sampling transfer device of the present disclosure enables integrated blood collection and plasma creation in a closed system without centrifugation. The clinician may collect and separate the blood sample and then immediately transfer the plasma portion to the point-of-care testing device without further manipulation. This enables collection and transfer of plasma to the point-of-care testing device without exposure to blood. In addition, the blood sampling transfer device of the present disclosure minimizes process time by processing the blood within the blood sampling transfer device and without external machinery. Further, for tests which only require small amounts of blood, it eliminates the waste associated with blood collection and plasma separation with an evacuated tube.
In accordance with an embodiment of the present invention, a biological fluid transfer device adapted to receive a multi-component blood sample includes a housing having an inlet port and a transfer port, with the inlet port and the transfer port in fluid communication. The device also includes a mixing channel in fluid communication with the inlet port and the transfer port and shaped to promote mixing of the multi-component blood sample, and a blood separation element disposed between the inlet port and the transfer port. The blood separation element is adapted to restrain a first component of the multi-component blood sample and allow a second component of the multi-component blood sample to pass therethrough.
In one configuration, the first component is a cellular portion of the multi-component blood sample and the second component is a plasma portion of the multi-component blood sample. The mixing channel may include a sample stabilizer. In certain configurations, the inlet port is adapted to receive the multi-component blood sample via connection to a blood collection set. In other configurations, the inlet port is adapted to receive the multi-component blood sample via connection to a capillary device. In still other configurations, the inlet port is adapted to receive the multi-component blood sample via connection to a needle device. In still another configuration, the inlet port is adapted to receive the multi-component blood sample via connection to an intravenous line.
Optionally, the device may also include a wicking membrane adapted to cause the multi-component blood sample to flow into the biological fluid transfer device. The transfer port may include a bellows and a septum transitionable between a closed position and an open position, wherein compression of the bellows actuates the septum from the closed position to the open position. The mixing channel may include a sample stabilizer and the biological fluid transfer device may be a plasma preparation cartridge.
In accordance with another embodiment of the present invention, a biological fluid sampling system, such as a blood sampling system, includes a biological fluid transfer device adapted to receive a multi-component blood sample. The biological fluid transfer device includes a housing having an inlet port and a transfer port, with the inlet port and the transfer port in fluid communication. The device also includes a mixing channel in fluid communication with the inlet port and the transfer port and shaped to promote mixing of the blood sample, and a separation element disposed between the inlet port and the transfer port. The separation element is adapted to restrain a first component of the multi-component blood sample and allow a second component of the multi-component blood sample to pass therethrough. The system also includes a first interface removably connectable to the biological fluid transfer device, the first interface being adapted for connection to a first blood collection device. The system further includes a second interface removably connectable to the biological fluid transfer device, with the second interface being adapted for connection to a second blood collection device. The system also includes a packaging member having a compartment sized and adapted to receive the biological fluid transfer device, the first interface, and the second interface therein.
In certain configurations, the first component is a cellular portion of the multi-component blood sample and the second component is a plasma portion of the multi-component blood sample. The mixing channel may include a sample stabilizer. The inlet port may be adapted to receive the multi-component blood sample via a blood collection set. In other configurations, the inlet port may be adapted to receive the multi-component blood sample via an intravenous line. In other configurations, the inlet port may be adapted to receive the multi-component blood sample via a capillary device. In still other configurations, the inlet port may be adapted to receive the multi-component blood sample via connection to a needle device.
The device may also include a wicking membrane adapted to cause the multi-component blood sample to flow into the biological fluid sampling transfer device. The transfer port may include a bellows and a septum transitionable between a closed position and an open position, wherein compression of the bellows actuates the septum from the closed position to the open position. In certain configurations, the mixing channel includes a sample stabilizer and the biological fluid transfer device is a plasma preparation cartridge. Optionally, the first interface includes a spinlock interface. In another configuration, the second interface includes a capillary interface. In yet another configuration, the packaging member includes a blister package.
In accordance with yet another embodiment of the present invention, a biological fluid separation and testing system for a multi-component blood sample includes a blood sampling transfer device adapted to receive the multi-component blood sample. The blood sampling transfer device includes a housing having an inlet port and a transfer port, with the inlet port and the transfer port in fluid communication. The device also includes a mixing channel in fluid communication with the inlet port and the transfer port and shaped to promote mixing of the blood sample, and a separation element disposed between the inlet port and the transfer port, the separation element adapted to restrain a first component of the multi-component blood sample and allow a second component of the multi-component blood sample to pass therethrough. The system also includes a blood testing device having a receiving port adapted to receive the transfer port of the blood sampling transfer device for closed transfer of at least a portion of the second component from the blood sampling transfer device to the blood testing device.
In certain configurations, the first component is a cellular portion of the multi-component blood sample and the second component is a plasma portion of the multi-component blood sample. The mixing channel may include a sample stabilizer.
The above-mentioned and other features and advantages of this disclosure, and the manner of attaining them, will become more apparent and the disclosure itself will be better understood by reference to the following descriptions of embodiments of the disclosure taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the disclosure, and such exemplifications are not to be construed as limiting the scope of the disclosure in any manner.
The following description is provided to enable those skilled in the art to make and use the described embodiments contemplated for carrying out the invention. Various modifications, equivalents, variations, and alternatives, however, will remain readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to fall within the spirit and scope of the present invention.
For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures. However, it is to be understood that the invention may assume alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary embodiments of the invention. Hence, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered as limiting.
Various point-of-care testing devices are known in the art. Such point-of-care testing devices include test strips, glass slides, diagnostic cartridges, or other testing devices for testing and analysis. Test strips, glass slides, and diagnostic cartridges are point-of-care testing devices that receive a blood sample and test that blood for one or more physiological and biochemical states. There are many point-of-care devices that use cartridge based architecture to analyze very small amounts of blood bedside without the need to send the sample to a lab for analysis. This saves time in getting results over the long run but creates a different set of challenges versus the highly routine lab environment. Examples of such testing cartridges include the i-STAT® testing cartridge from the Abbot group of companies. Testing cartridges such as the i-STAT® cartridges may be used to test for a variety of conditions including the presence of chemicals and electrolytes, hematology, blood gas concentrations, coagulation, or cardiac markers. The results of tests using such cartridges are quickly provided to the clinician.
However, the samples provided to such point-of-care testing cartridges are currently manually collected with an open system and transferred to the point-of-care testing cartridge in a manual manner that often leads to inconsistent results, or failure of the cartridge leading to a repeat of the sample collection and testing process, thereby negating the advantage of the point-of-care testing device. Accordingly, a need exists for a system for collecting and transferring a sample to a point-of-care testing device that provides safer, reproducible, and more accurate results. Accordingly, a point-of-care collecting and transferring system of the present disclosure will be described hereinafter. A system of the present disclosure enhances the reliability of the point-of-care testing device by: 1) incorporating a more closed type of sampling and transfer system; 2) minimizing open exposure of the sample; 3) improving sample quality; 4) improving the overall ease of use; and 5) separating the sample at the point of collection.
Some of the advantages of the blood sampling transfer device and the blood separation and testing system of the present disclosure over prior systems are that it is a closed system which reduces blood sample exposure, it provides passive and fast mixing of the blood sample with a sample stabilizer, it facilitates separation of the blood sample without transferring the blood sample to a separate device, and it is capable of transferring pure plasma to a point-of-care testing device. The blood sampling transfer device of the present disclosure enables integrated blood collection and plasma creation in a closed system without centrifugation. The clinician may collect and separate the blood sample and then immediately transfer the plasma portion to the point-of-care testing device without further manipulation. This enables collection and transfer of plasma to the point-of-care testing device without exposure to blood. In addition, the blood sampling transfer device of the present disclosure minimizes process time by processing the blood within the blood sampling transfer device and without external machinery. Further, for tests which only require small amounts of blood, it eliminates the waste associated with blood collection and plasma separation with an evacuated tube.
Referring to
Referring to
The packaging member 36 includes a body or wall 46 defining a compartment 38. In one embodiment, the body 46 of the packaging member 36 defines a first compartment 40 sized and adapted to receive the blood sampling transfer device 10 therein, a second compartment 42 sized and adapted to receive the first interface 32 therein, and a third compartment 44 sized and adapted to receive the second interface 34 therein. In one embodiment, the packaging member 36 comprises a blister package. In one embodiment, a sealing cover is secured over the packaging member 36 to seal the blood sampling transfer device 10, the first interface 32, and the second interface 34 therein, i.e., the sealing cover provides a substantially impermeable enclosure with respect to packaging member 36, provides a leak prevention and protection enclosure, protects the contents of the blood sampling transfer device 10 and the interfaces 32, 34 contained within packaging member 36, and/or maintains a sealed, sterilized environment within packaging member 36. The sealing cover of the packaging member 36 provides a sufficient seal at a range of temperatures, pressures, and humidity levels. In one embodiment, tamper evidence is also provided by use of a tear strip or other indicating means secured to a portion of the sealing cover and/or packaging member 36 to indicate tampering with the contents of packaging member 36.
In one embodiment, the blood sampling transfer device 10 is a plasma preparation cartridge. In one embodiment, the first interface 32 is a spinlock interface. In one embodiment, the second interface 34 is a capillary collection interface. In one embodiment, the packaging member 36 is a blister package. The system of the present disclosure allows the blood sampling transfer device 10 to receive a blood sample from a variety of sources including, but not limited to, an integral micro-needle device or lancet device 62 (
In one embodiment, there are three primary ways a user can collect blood into the blood sampling transfer device 10. For example, these ways may be as follows: 1) venous blood via venipuncture and connecting to a blood collection set 100 or IV with the first interface 32 and a resealable valve or septum (arterial draws may be accomplished by connecting this interface system to an indwelling line); 2) capillary blood via a capillary stick with a lancet on a finger of the patient with the second interface 34; and 3) venous-like blood by using the micro-needle device 62 to puncture the arm of a patient. This universal approach offers the greatest flexibility in allowing the clinician to determine what is best for the patient under his or her care. In other embodiments, there are additional ways a user can collect blood into the blood sampling transfer device 10.
Referring to
Referring to
The blood sampling transfer device 10 also includes a layer of sample stabilizer 64. The sample stabilizer can be an anticoagulant, or a substance designed to preserve a specific element within the blood such as, for example, RNA, protein analyte, or other element. In one embodiment, the layer of sample stabilizer 64 may be disposed over the blood separation element 58. In one embodiment, a portion of the mixing channel 56 includes the sample stabilizer 64. In other embodiments, the layer of sample stabilizer 64 may be located anywhere between the inlet port 52 and the blood separation element 58. In this manner, as a blood sample 12 flows through the inlet port 52 and into the mixing channel 56, the blood sampling transfer device 10 provides passive and fast mixing of the blood sample 12 with the sample stabilizer 64.
The blood sampling transfer device 10 includes a blood separation element 58 disposed between the inlet port 52 and the transfer port 54. The blood separation element 58 is adapted to trap the cellular portion 14 of the blood sample 12 within the mixing channel 56 and allow the plasma portion 16 of the blood sample 12 to pass through the blood separation element 58 to the exit channel 68 as shown in
In one embodiment, the blood separation element 58 may be either hollow fiber membrane filters commercially available, or flat membrane filters, such as track-etch filters commercially available. Membrane filter pore size and porosity can be chosen to optimize separation of clean (i.e., red blood cell free, white blood cell free, and platelet free) plasma in an efficient manner. In another embodiment, the blood separation element 58 includes a lateral flow membrane. In other embodiments, the blood separation element 58 may comprise any filter that is able to trap the cellular portion 14 of the blood sample 12 within the mixing channel 56 and allow the plasma portion 16 of the blood sample 12 to pass through the blood separation element 58 to the exit channel 68.
Referring to
In one embodiment, the bottom surface 72 of the housing 50 includes an adhesive. In such an embodiment, the bottom surface 72 includes an adhesive so that the blood sampling transfer device 10 can be secured onto a skin surface of a patient where a blood sample will be accessed using the lancet or micro-needle device 62. In one embodiment, the adhesive of the bottom surface 72 is protected by a peel-off layer, similar to an adhesive bandage, which would be removed before placing the blood sampling transfer device 10 on the skin surface of the patient's body. A hydrogel or other layer (not shown) could be included to provide some thickness to the bottom surface 72 and help improve the stability of the adhesive seal. Additionally, in one embodiment, the adhesive could include a chemistry to create a more liquid-tight seal, similar to painter's tape technology, where wetting from the paint itself causes a chemical reaction with the adhesive to create a more water-tight barrier to prevent the paint from seeping under the tape. In certain cases, the blood sample collected on a top surface of the adhesive tape may be of better quality than blood samples collected by use of a typical lancet by minimizing contact with the skin surface.
Referring to
Referring to
As discussed above, the transfer port 54 of the blood sampling transfer device 10 may include a valve or septum 86 that is transitionable between a closed position and an open position. With the valve or septum 86 in an open position (
In one embodiment, referring to
Referring to
The valve 86 of the blood sampling transfer device 10 only opens when the transfer port 54 is pressed upon the receiving port 24 of the point-of-care testing device 22. This releases the isolated plasma portion 16 directly into the receiving port 24 of the point-of-care testing device 22, thus mitigating unnecessary exposure to the patient's blood.
Referring to
Once a desired method or source is selected, the interface connection portion 60 of the blood sampling transfer device 10 allows the first interface 32 or the second interface 34 to be removably connected to the blood sampling transfer device 10 to allow for the collection of a blood sample 12 into the blood sampling transfer device 10. The blood sampling transfer device 10 is designed to be a closed system for blood collection from various collection sites as described above. Once blood enters the blood sampling transfer device 10 from one of the above selected sources, it is mixed with a sample stabilizer as it travels through the microfluidic mixing channel 56 via capillary action. Next, the blood sample 12 travels through the mixing channel 56 and the blood separation element 58 is adapted to trap the cellular portion 14 of the blood sample 12 within the mixing channel 56 and allow the plasma portion 16 of the blood sample 12 to pass through the blood separation element 58 to the exit channel 68 as shown in
After disconnecting or removing the blood sampling transfer device 10 from the selected source, the blood sampling transfer device 10 may be engaged with a blood testing device 22. The transfer port 54 may be placed over the receiving port 24 of the point-of-care testing device 22 as shown in
Some of the advantages of the blood sampling transfer device and the blood separation and testing system of the present disclosure over prior systems are that it is a closed system which reduces blood sample exposure, it provides passive and fast mixing of the blood sample with a sample stabilizer, it facilitates separation of the blood sample without transferring the blood sample to a separate device, and it is capable of transferring pure plasma to the point-of-care testing device 22. The blood sampling transfer device of the present disclosure enables integrated blood collection and plasma creation in a closed system without centrifugation. The clinician may collect and separate the blood sample and then immediately transfer the plasma portion to the point-of-care testing device 22 without further manipulation. This enables collection and transfer of plasma to the point-of-care testing device 22 without exposure to blood. In addition, the blood sampling transfer device of the present disclosure minimizes process time by processing the blood within the blood sampling transfer device and without external machinery. Further, for tests which only require small amounts of blood, it eliminates the waste associated with blood collection and plasma separation with an evacuated tube.
While this disclosure has been described as having exemplary designs, the present disclosure can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this disclosure pertains and which fall within the limits of the appended claims.
The present application is a continuation of U.S. application Ser. No. 16/425,015, filed May 29, 2019, entitled “Biological Fluid Transfer Device and Biological Fluid Sampling System”, which is a continuation of U.S. application Ser. No. 14/251,681, filed Apr. 14, 2014, entitled “Biological Fluid Transfer Device and Biological Fluid Sampling System” (now U.S. Pat. No. 10,342,471), which claims priority to U.S. Provisional Application No. 61/811,918, filed Apr. 15, 2013, entitled “Medical Device for Collection of a Biological Sample”, the entire disclosures of each of which are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3159159 | Cohen | Dec 1964 | A |
| 3322114 | Portnoy et al. | May 1967 | A |
| 3640393 | Hurtig | Feb 1972 | A |
| 3848579 | Villa-Real | Nov 1974 | A |
| 4134512 | Nugent | Jan 1979 | A |
| 4146172 | Cullis et al. | Mar 1979 | A |
| 4436098 | Kaufman | Mar 1984 | A |
| 4511349 | Nielsen et al. | Apr 1985 | A |
| 4627445 | Garcia et al. | Dec 1986 | A |
| 4842591 | Luther | Jun 1989 | A |
| 4999304 | Robertson | Mar 1991 | A |
| 5055203 | Columbus | Oct 1991 | A |
| 5160702 | Kopf-Sill et al. | Nov 1992 | A |
| 5163442 | Ono | Nov 1992 | A |
| 5219999 | Suzuki et al. | Jun 1993 | A |
| 5242606 | Braynin et al. | Sep 1993 | A |
| 5304348 | Burd et al. | Apr 1994 | A |
| 5364533 | Ogura | Nov 1994 | A |
| 5422018 | Saunders et al. | Jun 1995 | A |
| 5578459 | Gordon | Nov 1996 | A |
| 5636640 | Staehlin | Jun 1997 | A |
| 5638828 | Lauks et al. | Jun 1997 | A |
| 5657963 | Hinchliffe et al. | Aug 1997 | A |
| 5690618 | Smith et al. | Nov 1997 | A |
| 5726026 | Wilding et al. | Mar 1998 | A |
| 5733446 | Holm | Mar 1998 | A |
| 5839715 | Leinsing | Nov 1998 | A |
| 5879624 | Boehringer et al. | Mar 1999 | A |
| 5922591 | Anderson et al. | Jul 1999 | A |
| 5979669 | Kitajima et al. | Nov 1999 | A |
| 6063039 | Cunningham et al. | May 2000 | A |
| 6074183 | Allen et al. | Jun 2000 | A |
| 6170671 | Kitajima et al. | Jan 2001 | B1 |
| 6264619 | Ferguson | Jul 2001 | B1 |
| 6372182 | Mauro et al. | Apr 2002 | B1 |
| 6506167 | Ishimito et al. | Jan 2003 | B1 |
| 6537242 | Palmer | Mar 2003 | B1 |
| 6613064 | Rutynowski et al. | Sep 2003 | B2 |
| 6869405 | Marsden | Mar 2005 | B2 |
| 7001344 | Freeman et al. | Feb 2006 | B2 |
| 7014625 | Bengtsson | Mar 2006 | B2 |
| 7378259 | Bahatt et al. | May 2008 | B2 |
| 7678580 | Kuriger | Mar 2010 | B2 |
| 7803123 | Perez et al. | Sep 2010 | B2 |
| 8075496 | Deck et al. | Dec 2011 | B2 |
| 8114351 | Degenhardt | Feb 2012 | B2 |
| 8158410 | Tang et al. | Apr 2012 | B2 |
| 8163253 | Hartselle | Apr 2012 | B1 |
| 8211036 | Schraga | Jul 2012 | B2 |
| 8267911 | Gallogly et al. | Sep 2012 | B2 |
| 8328735 | Haar et al. | Dec 2012 | B2 |
| 8383044 | Davis et al. | Feb 2013 | B2 |
| 8469984 | Ruan et al. | Jun 2013 | B2 |
| 8470588 | Boehm et al. | Jun 2013 | B2 |
| 8491499 | Choi et al. | Jul 2013 | B2 |
| 8491840 | Cho et al. | Jul 2013 | B2 |
| 8764657 | Curry et al. | Jul 2014 | B2 |
| 9028425 | Burkholz | May 2015 | B2 |
| 9119578 | Haghgooie et al. | Sep 2015 | B2 |
| 9295417 | Haghgooie et al. | Mar 2016 | B2 |
| 9404075 | Pflanz | Aug 2016 | B2 |
| 9517026 | Gelfand et al. | Dec 2016 | B2 |
| 9549700 | Fletcher et al. | Jan 2017 | B2 |
| 9549701 | Peterson et al. | Jan 2017 | B2 |
| 20020009015 | Laugharn, Jr. et al. | Jan 2002 | A1 |
| 20020143298 | Marsden | Oct 2002 | A1 |
| 20030013205 | Konrad | Jan 2003 | A1 |
| 20030134416 | Yamanishi et al. | Jul 2003 | A1 |
| 20030232712 | Dolecek et al. | Dec 2003 | A1 |
| 20040069459 | Tonosaki et al. | Apr 2004 | A1 |
| 20040116830 | Trudeau et al. | Jun 2004 | A1 |
| 20040142463 | Walker et al. | Jul 2004 | A1 |
| 20040142493 | Hutchens et al. | Jul 2004 | A1 |
| 20040143226 | Marsden | Jul 2004 | A1 |
| 20040230216 | Levaughn et al. | Nov 2004 | A1 |
| 20040252584 | Ji | Dec 2004 | A1 |
| 20050004494 | Perez | Jan 2005 | A1 |
| 20050015020 | Levaughn et al. | Jan 2005 | A1 |
| 20050026301 | Petithory | Feb 2005 | A1 |
| 20050133439 | Blickhan | Jun 2005 | A1 |
| 20050139547 | Manoussakis et al. | Jun 2005 | A1 |
| 20050196872 | Nguyen et al. | Sep 2005 | A1 |
| 20050214927 | Haley | Sep 2005 | A1 |
| 20050273019 | Conway et al. | Dec 2005 | A1 |
| 20060009713 | Flaherty | Jan 2006 | A1 |
| 20060029923 | Togawa et al. | Feb 2006 | A1 |
| 20060127277 | Numajiri | Jun 2006 | A1 |
| 20060160243 | Tang et al. | Jul 2006 | A1 |
| 20060228258 | Samsoondar | Oct 2006 | A1 |
| 20060228259 | Samsoondar | Oct 2006 | A1 |
| 20060229530 | Hosoda et al. | Oct 2006 | A1 |
| 20060240964 | Lolachi et al. | Oct 2006 | A1 |
| 20070031283 | Davis et al. | Feb 2007 | A1 |
| 20070160503 | Sethu et al. | Jul 2007 | A1 |
| 20070265549 | Channer et al. | Nov 2007 | A1 |
| 20080097315 | Miner et al. | Apr 2008 | A1 |
| 20080135502 | Pyo et al. | Jun 2008 | A1 |
| 20080176068 | Neubert et al. | Jul 2008 | A1 |
| 20080240990 | Flaherty | Oct 2008 | A1 |
| 20080287906 | Burkholz et al. | Nov 2008 | A1 |
| 20090004060 | Omuro et al. | Jan 2009 | A1 |
| 20090105614 | Momose et al. | Apr 2009 | A1 |
| 20090120865 | Chung et al. | May 2009 | A1 |
| 20090136982 | Tang et al. | May 2009 | A1 |
| 20090181411 | Battrell et al. | Jul 2009 | A1 |
| 20090204026 | Crawford et al. | Aug 2009 | A1 |
| 20090281525 | Harding et al. | Nov 2009 | A1 |
| 20090286309 | Roderfeld | Nov 2009 | A1 |
| 20100021910 | Cao | Jan 2010 | A1 |
| 20100089815 | Zhang et al. | Apr 2010 | A1 |
| 20100093551 | Montagu | Apr 2010 | A1 |
| 20100198108 | Alden | Aug 2010 | A1 |
| 20100241031 | Lai | Sep 2010 | A1 |
| 20110009717 | Davis et al. | Jan 2011 | A1 |
| 20110058985 | Saiki et al. | Mar 2011 | A1 |
| 20110092784 | Butler et al. | Apr 2011 | A1 |
| 20110124130 | Wagner et al. | May 2011 | A1 |
| 20110124984 | Rostaing | May 2011 | A1 |
| 20110134426 | Kaduchak et al. | Jun 2011 | A1 |
| 20110263030 | Kim | Oct 2011 | A1 |
| 20120016213 | Burkholz | Jan 2012 | A1 |
| 20120134974 | Sehgal | May 2012 | A1 |
| 20120152858 | Yang | Jun 2012 | A1 |
| 20120275955 | Haghgooie et al. | Nov 2012 | A1 |
| 20120277696 | Gonzalez-Zugasti et al. | Nov 2012 | A1 |
| 20120277697 | Haghgooie et al. | Nov 2012 | A1 |
| 20130026085 | Samsoondar | Jan 2013 | A1 |
| 20130040333 | Karlsson | Feb 2013 | A1 |
| 20130052675 | Karlsson et al. | Feb 2013 | A1 |
| 20130082012 | Lean et al. | Apr 2013 | A1 |
| 20130086980 | Gadini et al. | Apr 2013 | A1 |
| 20130165867 | Isaacson et al. | Jun 2013 | A1 |
| 20130175213 | Dorrer et al. | Jul 2013 | A1 |
| 20130209331 | Rodenfels et al. | Aug 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 1169886 | Jan 1998 | CN |
| 1262606 | Aug 2000 | CN |
| 1382966 | Dec 2002 | CN |
| 1525834 | Sep 2004 | CN |
| 1846603 | Oct 2006 | CN |
| 1929782 | Mar 2007 | CN |
| 1993079 | Jul 2007 | CN |
| 101102847 | Jan 2008 | CN |
| 101288592 | Oct 2008 | CN |
| 101317758 | Dec 2008 | CN |
| 101332320 | Dec 2008 | CN |
| 101600963 | Dec 2009 | CN |
| 101695446 | Apr 2010 | CN |
| 102429665 | May 2012 | CN |
| 102573629 | Jul 2012 | CN |
| 102764133 | Nov 2012 | CN |
| 202714857 | Feb 2013 | CN |
| 202844313 | Apr 2013 | CN |
| 202008010918 | Dec 2008 | DE |
| 0376168 | Jul 1990 | EP |
| 0747105 | Dec 1996 | EP |
| 1096254 | May 2001 | EP |
| 1106065 | Jun 2001 | EP |
| 1477804 | Nov 2004 | EP |
| 1602329 | Dec 2005 | EP |
| 1627651 | Feb 2006 | EP |
| 2264453 | Dec 2010 | EP |
| 2413138 | Feb 2012 | EP |
| 2929135 | Oct 2009 | FR |
| 2977808 | Jan 2013 | FR |
| 51162582 | Jun 1950 | JP |
| S544191 | Jan 1979 | JP |
| H01297159 | Nov 1989 | JP |
| H0275332 | Mar 1990 | JP |
| H04276258 | Oct 1992 | JP |
| H07500910 | Jan 1995 | JP |
| H07503794 | Apr 1995 | JP |
| 200074908 | Mar 2000 | JP |
| 200319126 | Jan 2003 | JP |
| 2004150891 | May 2004 | JP |
| 2004354387 | Dec 2004 | JP |
| 2004361419 | Dec 2004 | JP |
| 2005270729 | Oct 2005 | JP |
| 2005287955 | Oct 2005 | JP |
| 2005349195 | Dec 2005 | JP |
| 200668384 | Mar 2006 | JP |
| 2006214955 | Aug 2006 | JP |
| 2006218447 | Aug 2006 | JP |
| 200750100 | Mar 2007 | JP |
| 2007249306 | Sep 2007 | JP |
| 2007315879 | Dec 2007 | JP |
| 2008157960 | Jul 2008 | JP |
| 2008302077 | Dec 2008 | JP |
| 2009128367 | Jun 2009 | JP |
| 2009264858 | Nov 2009 | JP |
| 2010505096 | Feb 2010 | JP |
| 2010146123 | Jul 2010 | JP |
| 2010147371 | Jul 2010 | JP |
| 2010237050 | Oct 2010 | JP |
| 201155916 | Mar 2011 | JP |
| 2012530256 | Nov 2012 | JP |
| 2012532683 | Dec 2012 | JP |
| 2013518276 | May 2013 | JP |
| 5508709 | Jun 2014 | JP |
| 1020100007809 | Jan 2010 | KR |
| 9118656 | Dec 1991 | WO |
| 9309710 | May 1993 | WO |
| 2005018710 | Mar 2005 | WO |
| 2006047831 | May 2006 | WO |
| 2007002579 | Jan 2007 | WO |
| 2009123592 | Oct 2009 | WO |
| 2011040874 | Apr 2011 | WO |
| 2011093602 | Aug 2011 | WO |
| 2012121686 | Sep 2012 | WO |
| Entry |
|---|
| Amasia et al., “Large-volume centrifugal microfluidic device for blood plasma separation”, Bioanalysis, 2010, pp. 1701-1710, vol. 2:10. |
| Lee, “A fully automated immunoassay from whole blood on a disc”, Lab Chip, 2009, pp. 1548-1555, vol. 9. |
| Membrane Separation Technology for Research and Quality Control, Sartorius AG, Separation Technology, Laboratory Filtration, Mar. 1, 1997. |
| Zehnle, “Centrifugo-dynamic inward pumping of liquids on a centrifugal micofluidic platform”, 2012, Royal Society of Chemistry, Lab Chip, pp. 5142-5145, vol. 12. |
| Number | Date | Country | |
|---|---|---|---|
| 20200397359 A1 | Dec 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61811918 | Apr 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16425015 | May 2019 | US |
| Child | 17007875 | US | |
| Parent | 14251681 | Apr 2014 | US |
| Child | 16425015 | US |
